Water-Based Iron Suspension for Neonatal Animals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for administering iron supplements to neonatal animals are painful, inefficient, and often result in adverse effects, such as injection site infections and gastrointestinal toxicity, due to the use of parenteral injections and oil-based oral supplements that are difficult to administer and have low iron concentrations.

Innovation Solution

A water-based oral veterinary suspension containing iron fumarate or iron sulfate, along with a suspending agent like xanthan gum, which is easier to administer and provides a stable source of iron, reducing the risk of adverse effects and improving bioavailability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If parenteral injection of iron dextran is used, then iron supplementation is effective, but the animals suffer from painful injections, injection site infections, and potential toxic effects

Engineering Contradiction:
Improveeffectiveness of iron supplementationVSAvoidpain, infection risk, and toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses an oral administration route as an intermediary method between parenteral injection and feed supplementation. The iron supplement is delivered through a liquid composition that can be easily administered orally, avoiding direct injection into tissues while still providing effective iron supplementation. This intermediary approach eliminates the harmful effects of injections (pain, infection risk) while maintaining reliability of iron delivery.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the physical and chemical parameters of iron supplementation by using water-based liquid compositions with specific iron salts (ferrous fumarate, ferrous sulfate) instead of oil-based pastes or injectable forms. The liquid formulation with optimized iron concentration (100-500 mg/mL) and pH (2-7) improves safety and reduces toxicity while maintaining effectiveness.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If feed supplements are used, then iron can be provided voluntarily, but neonatal animals have unreliable intake and incomplete absorption due to undeveloped molecular absorption mechanisms

Engineering Contradiction:
Improvevoluntary intakeVSAvoidconsistency and completeness of iron delivery
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent prepares a pre-formulated liquid iron supplement that is ready for direct administration to neonatal animals. This preliminary preparation ensures the iron is in an optimally absorbable form and concentration before administration, addressing the incomplete absorption issue. The liquid formulation is designed to be easily ingestible while providing reliable, consistent iron delivery that doesn't depend on the animal's voluntary feeding behavior.

Inventive Principle:
Principle #10Preliminary action

3Loss of time

If oil-based paste supplements are used, then single-dose administration is possible, but the supplements are difficult to administer and become rancid, decreasing palatability and effectiveness

Engineering Contradiction:
Improvesingle-dose convenienceVSAvoiddifficulty of administration
Core Design Contradiction:
Loss of timeVSEase of operation

Solution Approach 1:

The patent fundamentally changes the base medium from oil to water, creating a water-based liquid composition. This parameter change eliminates the rancidity problem inherent in oil-based pastes, improves palatability, and makes the supplement easier to administer. The liquid form allows for simple oral delivery without the mechanical difficulties of forcing paste into neonatal animals, while maintaining single-dose convenience.

Inventive Principle:
Principle #35Parameter changes

4Object-affected harmful factors

If typical iron formulations with low iron concentrations are used, then the formulations are safer, but large treatment volumes are required which result in aspiration and regurgitation

Engineering Contradiction:
ImprovesafetyVSAvoidtreatment volume required
Core Design Contradiction:
Object-affected harmful factorsVSQuantity of substance

Solution Approach 1:

The patent optimizes the iron concentration parameter to a specific range (100-500 mg/mL) that balances safety and dosing volume. This concentration range provides sufficient iron per unit volume to prevent aspiration and regurgitation while maintaining safety through controlled delivery. The water-based liquid formulation with this optimized concentration allows for smaller, safer treatment volumes compared to traditional low-concentration formulations.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The water-based suspension effectively treats and prevents iron deficiencies in neonatal animals by providing a stable and palatable source of iron, reducing the risk of adverse effects and improving bioavailability, with increased shelf-life and ease of administration compared to conventional methods.

Implementation Method 1

water and an iron salt that is iron fumarate, an iron sulfate, or a combination thereof suspended in the water. The suspension also comprises a suspending agent.

Methodology Applied
Scientific EffectSuspension: Suspension

Data Source

PatentUS20240366657A1Water-based iron supplement formulations for dosing animal neonates
Publication Date: 2024.11.07 ALBERTA VETERINARY LAB LTD
  • US20240366657A1 patent drawing
  • US20240366657A1 patent drawing

AI summary

Disclosed are oral veterinary suspensions for delivering supplemental iron to a neonatal animal. The oral veterinary suspensions comprise water, an iron salt that is iron fumarate, iron sulfate, or a combination thereof suspended in the water, and a suspending agent. Also disclosed are methods of treating or preventing iron deficiencies to neonatal animals, as well as uses of the oral veterinary suspensions.